VJOncology is committed to improving our service to you

ESMO Breast 2020 | Endocrine therapy in premenopausal women with HR+ breast cancer

VJOncology is committed to improving our service to you

Michael Gnant

Michael Gnant, MD, Vienna General Hospital, Vienna, Austria, discusses the management of endocrine therapy in premenopausal women with hormone receptor-positive (HR+) breast cancer. Prof. Gnant outlines the most common side effects of endocrine therapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter